Harvey N C, Glüer C C, Binkley N, McCloskey E V, Brandi M-L, Cooper C, Kendler D, Lamy O, Laslop A, Camargos B M, Reginster J-Y, Rizzoli R, Kanis J A
MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK; NIHR Southampton Nutrition Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.
Sektion Biomedizinische Bildgebung, Klinik für Radiologie und Neuroradiologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Bone. 2015 Sep;78:216-24. doi: 10.1016/j.bone.2015.05.016. Epub 2015 May 16.
Trabecular bone score (TBS) is a recently-developed analytical tool that performs novel grey-level texture measurements on lumbar spine dual X-ray absorptiometry (DXA) images, and thereby captures information relating to trabecular microarchitecture. In order for TBS to usefully add to bone mineral density (BMD) and clinical risk factors in osteoporosis risk stratification, it must be independently associated with fracture risk, readily obtainable, and ideally, present a risk which is amenable to osteoporosis treatment. This paper summarizes a review of the scientific literature performed by a Working Group of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis. Low TBS is consistently associated with an increase in both prevalent and incident fractures that is partly independent of both clinical risk factors and areal BMD (aBMD) at the lumbar spine and proximal femur. More recently, TBS has been shown to have predictive value for fracture independent of fracture probabilities using the FRAX® algorithm. Although TBS changes with osteoporosis treatment, the magnitude is less than that of aBMD of the spine, and it is not clear how change in TBS relates to fracture risk reduction. TBS may also have a role in the assessment of fracture risk in some causes of secondary osteoporosis (e.g., diabetes, hyperparathyroidism and glucocorticoid-induced osteoporosis). In conclusion, there is a role for TBS in fracture risk assessment in combination with both aBMD and FRAX.
小梁骨评分(TBS)是一种最近开发的分析工具,它对腰椎双能X线吸收测定法(DXA)图像进行新颖的灰度纹理测量,从而获取与小梁微结构相关的信息。为了使TBS能在骨质疏松症风险分层中有效地补充骨矿物质密度(BMD)和临床风险因素,它必须与骨折风险独立相关、易于获得,并且理想情况下,呈现出适合骨质疏松症治疗的风险。本文总结了骨质疏松症和骨关节炎临床与经济学会工作组对科学文献的综述。低TBS始终与既往骨折和新发骨折的增加相关,这种增加部分独立于临床风险因素以及腰椎和股骨近端的面积骨密度(aBMD)。最近,已证明TBS对于使用FRAX®算法的骨折具有独立于骨折概率的预测价值。尽管TBS会随着骨质疏松症治疗而变化,但其变化幅度小于脊柱的aBMD,并且尚不清楚TBS的变化与骨折风险降低之间的关系。TBS在某些继发性骨质疏松症(如糖尿病、甲状旁腺功能亢进和糖皮质激素性骨质疏松症)的骨折风险评估中可能也有作用。总之,TBS在结合aBMD和FRAX进行骨折风险评估中具有一定作用。